Conversion from Epoetin Alfa to Darbepoetin Alfa for Management of Anaemia in a Community Chronic Kidney Disease Centre: A Retrospective Cohort Study

By Gobin Jaya   Cernii Aura   McLean Rosella   Finkelstein Fredric O.   Simon David B.  

Clinical Drug Investigation, Vol. 31, Iss. 2, 2011-02 ,pp. : 113-120

Adis International

Access to resources Recommend Favorite

An Extended Terminal Half-Life for Darbepoetin Alfa: Results from a Single-Dose Pharmacokinetic Study in Patients with Chronic Kidney Disease not Receiving Dialysis

By Padhi Desmond   Ni Liyun   Cooke Blaire   Marino Rafael   Jang Graham  

Clinical Pharmacokinetics, Vol. 45, Iss. 5, 2006-01 ,pp. : 503-510

Adis International

Access to resources Recommend Favorite

Population pharmacokinetics of darbepoetin alfa in peritoneal dialysis and non-dialysis patients with chronic kidney disease after single subcutaneous administration

By Kawakami Kazuki   Takama Hirotaka   Nakashima Daisuke   Tanaka Hideji   Uchida Eiji   Akizawa Tadao  

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 169-178

Springer Publishing Company

Access to resources Recommend Favorite

The combination of darbepoetin alfa and IV iron sucrose is effective in increasing haemoglobin levels

By  

Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil in Elderly Patients with Essential or Isolated Systolic Hypertension: Efficacy and Safety Data from Clinical Trials

By Heagerty Anthony M.  

Drugs & Aging, Vol. 26, Iss. 1, 2009-01 ,pp. : 61-76

Adis International

Access to resources Recommend Favorite